Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04540536 · ClinicalTrials.gov registry record · NA

Feasibility and Effectiveness of Real-time, Remote Continuous Glucose Monitoring in Adolescents With Poorly Controlled Type 1 Diabetes

A NA study, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT04540536 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04540536, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

Adolescents with Type 1 Diabetes (age 13-18 years, T1D duration \>6 months managed on insulin) and poor glycemic control will wear a blinded CGM to obtain baseline data. After assuring adherence to CGM wear, participants will receive a non-blinded CGM and will share their blood glucose levels with the study team. Clinical personnel will remotely monitor patients in real-time for 3 months and communicate regularly over secure text messaging with participants and their parents. Following active remote monitoring, the participants will wear a non-blinded CGM for 3 months. Primary outcome assessment will be the change in HbA1c after 3 months of real-time remote continuous glucose monitoring.

Interventions

  • OTHER Continuous Glucose Monitoring
  • OTHER Secure texting

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2021-11-01
Est. Completion 2024-12-01
Phase NA

What the Registry Record Tells You About NCT04540536

The ClinicalTrials.gov registry entry for NCT04540536 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Continuous Glucose Monitoring is the first listed.

NCT04540536 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04540536 about?

NCT04540536 is a clinical study titled "Feasibility and Effectiveness of Real-time, Remote Continuous Glucose Monitoring in Adolescents With Poorly Controlled Type 1 Diabetes". Adolescents with Type 1 Diabetes (age 13-18 years, T1D duration \>6 months managed on insulin) and poor glycemic control will wear a blinded CGM to obtain baseline data. After assuring adherence to CGM wear, participants will receive a non-blinded CGM and will share their blood glucose levels with t...

What is the current status of trial NCT04540536?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-11-01. Estimated completion is 2024-12-01.

What interventions are being tested in trial NCT04540536?

The interventions under investigation include: Continuous Glucose Monitoring (OTHER), Secure texting (OTHER).

Who is sponsoring clinical trial NCT04540536?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.